GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021)

GeneDx Holdings (WGS) reported Long-Term Investments of $442.8 million for Q2 2021, little changed quarter-over-quarter from $442.8 million in Q1 2021.

GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has 2 years of Long-Term Investments data on file, last reported at $442.8 million in Q2 2021.

  • Long-Term Investments for Q2 2021 came in at $442.8 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $442.8 million (changed N/A YoY), and the FY2020 annual result was $442.8 million, changed N/A from the prior year.
  • Long-Term Investments steadied at $442.8 million in Q2 2021 per WGS's latest filing, from $442.8 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $442.8 million in Q2 2021 and troughed at $442.8 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn 136.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn 357.00 Mn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 GeneDx Holdings 1.65 Bn 1.48 Bn 68.21 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 442.79 Mn
Mar 31, 2021 442.77 Mn
Dec 31, 2020 442.76 Mn
Sep 30, 2020 442.75 Mn